Biotech, Pharma ETFs Leave Pricing Drama Behind

Biotechnology and pharmaceutical ETFs have rallied in recent weeks as drug pricing concerns wane and investors look to the opportunity of this market segment. The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotechnology exchange traded fund by assets, rose 14.2% over the past month while the PowerShares Dynamic Pharmaceuticals Portfolio (NYSEArca: PJP), the largest pharma-related ETF, [...]Click to read more at